Literature DB >> 29164578

miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1.

Z-Y Feng1, X-H Xu, D-Z Cen, C-Y Luo, S-B Wu.   

Abstract

OBJECTIVE: Colon cancer is one of the most common and deadly types of gastrointestinal tumor. Despite progressive treatments, the patient prognosis has not been improved effectively.
MATERIALS AND METHODS: Expression of miRNA and mRNA were tested by Realtime PCR. Cell cycle was detected by flow cytometry. Cell viability was evaluated by MTT assay. Cell spheroid formation was determined by colony assay. Wnt signaling pathway activity was evaluated by TOP/FOP ratio. Protein expression was tested using Western blot. β-catenin binding ability was detected by ChIP assay. miRNA target gene was confirmed by luciferase assay.
RESULTS: miR-590-3p was found to be overexpressed in both glioma tissues and cell lines. miR-590-3p is upregulated in colon cancer cells and tissues compared to non-tumorigenic colon cells and normal colon tissues. miR-590-3p positively regulated cell proliferation, spheroid formation, and cell cycle in LS174T cells. Conversely, inhibition of miR-590-3p reduced these effects. We confirmed that WIF1 and DKK1 are targets of miR-590-3p. Overexpression of miR-590-3p promoted TOP flash luciferase activity, enhanced nuclear β-catenin levels and increased target genes expression of Wnt signaling pathway. The results indicated that miR-590-3p activates the Wnt/β-catenin signaling pathway.
CONCLUSIONS: We demonstrate that miR-590-3p regulates colon cancer progression via WIF1 and DKK1, which suggests that miR-590-3p may be a promising candidate for therapeutic applications in colon cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29164578

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  16 in total

Review 1.  MicroRNAs regulating Wnt signaling pathway in colorectal cancer: biological implications and clinical potentials.

Authors:  Faeze Ahmadi Beni; Mohammad Kazemi; Hassan Dianat-Moghadam; Mohadeseh Behjati
Journal:  Funct Integr Genomics       Date:  2022-10-20       Impact factor: 3.674

2.  Hsa-MiR-590-3p Promotes the Malignancy Progression of Pancreatic Ductal Carcinoma by Inhibiting the Expression of p27 and PPP2R2A via G1/S Cell Cycle Pathway.

Authors:  Xiaoyang Shi; Weiwei Sheng; Chao Jia; Jingtong Tang; Ming Dong
Journal:  Onco Targets Ther       Date:  2020-10-29       Impact factor: 4.147

3.  DKK1 inhibits breast cancer cell migration and invasion through suppression of β-catenin/MMP7 signaling pathway.

Authors:  Jie Niu; Xiao-Meng Li; Xiao Wang; Chao Liang; Yi-Dan Zhang; Hai-Ying Li; Fan-Ye Liu; Hua Sun; Song-Qiang Xie; Dong Fang
Journal:  Cancer Cell Int       Date:  2019-06-24       Impact factor: 5.722

4.  MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B.

Authors:  Liang Sun; Jun Xiang Lian; Shu Meng
Journal:  Cell Mol Biol Lett       Date:  2019-03-28       Impact factor: 5.787

5.  Long Non-Coding RNA HAND2-AS1 Inhibits Growth and Migration of Gastric Cancer Cells Through Regulating the miR-590-3p/KCNT2 Axis.

Authors:  Lan Yu; Hui Li; Zhiying Li; Jianchao Jia; Zhouying Wu; Min Wang; Feng Li; Zongqi Feng; Huilin Xia; Guanxin Gao
Journal:  Onco Targets Ther       Date:  2020-04-16       Impact factor: 4.147

6.  Biliverdin Reductase A (BLVRA) Promotes Colorectal Cancer Cell Progression by Activating the Wnt/β-Catenin Signaling Pathway.

Authors:  Haiyan Mao; Yuan Xu; Zhengrong Zhang; Guozhuang Sun; Zhu Wang; Dawei Qiao; Xudong Yin; Siping Liu; Ping Bo
Journal:  Cancer Manag Res       Date:  2020-04-23       Impact factor: 3.989

7.  MicroRNA-937 is overexpressed and predicts poor prognosis in patients with colon cancer.

Authors:  Huiya Liu; Lin Ma; Ling Wang; Yizuo Yang
Journal:  Diagn Pathol       Date:  2019-12-19       Impact factor: 2.644

8.  microRNA-544 promoted human osteosarcoma cell proliferation by downregulating AXIN2 expression.

Authors:  Ming Chen; Yong-Yi Liu; Min-Qing Zheng; Xin-Liang Wang; Xing-Hua Gao; Lin Chen; Guang-Ming Zhang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

9.  Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer.

Authors:  Yuansheng Ding; Xiaoyan Li; Yucui Zhang; Jie Zhang
Journal:  Cancer Manag Res       Date:  2020-02-20       Impact factor: 3.989

10.  Long Noncoding RNA LOC400043 (LINC02381) Inhibits Gastric Cancer Progression Through Regulating Wnt Signaling Pathway.

Authors:  Meisam Jafarzadeh; Bahram M Soltani
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.